IBD patients that have mutations in the IL10 or IL10R genes suffer from very severe intestinal disease which indeed highlights that Tr1-mediated IL-10 signaling maintains tolerance to commensal microbiota in the gut. Here, IL10 is linked to inflammatory bowel disease.